112 related articles for article (PubMed ID: 38105755)
1. OTUD6A in tubular epithelial cells mediates angiotensin II-induced kidney injury by targeting STAT3.
Sun X; Chen S; Zhao Y; Wu T; Zhao Z; Luo W; Han J; Fang Z; Ye B; Cao G; Huang S; Liang G
Am J Physiol Cell Physiol; 2024 Feb; 326(2):C400-C413. PubMed ID: 38105755
[TBL] [Abstract][Full Text] [Related]
2. Ang II (Angiotensin II)-Induced FGFR1 (Fibroblast Growth Factor Receptor 1) Activation in Tubular Epithelial Cells Promotes Hypertensive Kidney Fibrosis and Injury.
Xu Z; Luo W; Chen L; Zhuang Z; Yang D; Qian J; Khan ZA; Guan X; Wang Y; Li X; Liang G
Hypertension; 2022 Sep; 79(9):2028-2041. PubMed ID: 35862110
[TBL] [Abstract][Full Text] [Related]
3. OTUD1 promotes hypertensive kidney fibrosis and injury by deubiquitinating CDK9 in renal epithelial cells.
Wang MY; Yu TX; Wang QY; Han X; Hu X; Ye SJ; Long XH; Wang Y; Zhu H; Luo W; Liang G
Acta Pharmacol Sin; 2024 Apr; 45(4):765-776. PubMed ID: 38110583
[TBL] [Abstract][Full Text] [Related]
4. OTUD1 promotes pathological cardiac remodeling and heart failure by targeting STAT3 in cardiomyocytes.
Wang M; Han X; Yu T; Wang M; Luo W; Zou C; Li X; Li G; Wu G; Wang Y; Liang G
Theranostics; 2023; 13(7):2263-2280. PubMed ID: 37153745
[No Abstract] [Full Text] [Related]
5. Inhibition of STAT3 activation mediated by toll-like receptor 4 attenuates angiotensin II-induced renal fibrosis and dysfunction.
Xu Z; Zou C; Yu W; Xu S; Huang L; Khan Z; Wang J; Liang G; Wang Y
Br J Pharmacol; 2019 Jul; 176(14):2627-2641. PubMed ID: 30958891
[TBL] [Abstract][Full Text] [Related]
6. P300-dependent STAT3 acetylation is necessary for angiotensin II-induced pro-fibrotic responses in renal tubular epithelial cells.
Ni J; Shen Y; Wang Z; Shao DC; Liu J; Kong YL; Fu LJ; Zhou L; Xue H; Huang Y; Zhang W; Yu C; Lu LM
Acta Pharmacol Sin; 2014 Sep; 35(9):1157-66. PubMed ID: 25088002
[TBL] [Abstract][Full Text] [Related]
7. Deubiquitinase OTUD6a drives cardiac inflammation and hypertrophy by deubiquitination of STING.
Fang Z; Han J; Lin L; Ye B; Qu X; Zhang Y; Zhao Y; Xu D; Lin W; Shen S; Min J; Wu G; Huang Z; Liang G
Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167061. PubMed ID: 38342418
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of YAP activation attenuates renal injury and fibrosis in angiotensin II hypertensive mice.
Zhang J; Xu Q; Ren F; Liu Y; Cai R; Yao Y; Zhou MS
Can J Physiol Pharmacol; 2021 Oct; 99(10):1000-1006. PubMed ID: 33852804
[TBL] [Abstract][Full Text] [Related]
9. Deubiquitinase OTUD6A in macrophages promotes intestinal inflammation and colitis via deubiquitination of NLRP3.
Liu X; Fang Y; Lv X; Hu C; Chen G; Zhang L; Jin B; Huang L; Luo W; Liang G; Wang Y
Cell Death Differ; 2023 Jun; 30(6):1457-1471. PubMed ID: 36932155
[TBL] [Abstract][Full Text] [Related]
10. Deletion of Angiotensin-Converting Enzyme-2 Promotes Hypertensive Nephropathy by Targeting Smad7 for Ubiquitin Degradation.
Liu Z; Huang XR; Chen HY; Fung E; Liu J; Lan HY
Hypertension; 2017 Oct; 70(4):822-830. PubMed ID: 28808068
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of MyD88 attenuates angiotensin II-induced hypertensive kidney disease via regulating renal inflammation.
Lin K; Luo W; Yang N; Su L; Zhou H; Hu X; Wang Y; Khan ZA; Huang W; Wu G; Liang G
Int Immunopharmacol; 2022 Nov; 112():109218. PubMed ID: 36116148
[TBL] [Abstract][Full Text] [Related]
12. Critical role of CXCL16 in hypertensive kidney injury and fibrosis.
Xia Y; Entman ML; Wang Y
Hypertension; 2013 Dec; 62(6):1129-37. PubMed ID: 24060897
[TBL] [Abstract][Full Text] [Related]
13. Celastrol Attenuates Angiotensin II-Induced Cardiac Remodeling by Targeting STAT3.
Ye S; Luo W; Khan ZA; Wu G; Xuan L; Shan P; Lin K; Chen T; Wang J; Hu X; Wang S; Huang W; Liang G
Circ Res; 2020 Apr; 126(8):1007-1023. PubMed ID: 32098592
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of STAT3 acetylation is associated with angiotesin renal fibrosis in the obstructed kidney.
Ni J; Shen Y; Wang Z; Shao DC; Liu J; Fu LJ; Kong YL; Zhou L; Xue H; Huang Y; Zhang W; Yu C; Lu LM
Acta Pharmacol Sin; 2014 Aug; 35(8):1045-54. PubMed ID: 24976155
[TBL] [Abstract][Full Text] [Related]
15. Blockade of STAT3 signaling alleviates the progression of acute kidney injury to chronic kidney disease through antiapoptosis.
Park JY; Yoo KD; Bae E; Kim KH; Lee JW; Shin SJ; Lee JS; Kim YS; Yang SH
Am J Physiol Renal Physiol; 2022 May; 322(5):F553-F572. PubMed ID: 35311382
[TBL] [Abstract][Full Text] [Related]
16. Critical roles of SMYD2 lysine methyltransferase in mediating renal fibroblast activation and kidney fibrosis.
Liu L; Liu F; Guan Y; Zou J; Zhang C; Xiong C; Zhao TC; Bayliss G; Li X; Zhuang S
FASEB J; 2021 Jul; 35(7):e21715. PubMed ID: 34143514
[TBL] [Abstract][Full Text] [Related]
17. Deletion of STAT3 from Foxd1 cell population protects mice from kidney fibrosis by inhibiting pericytes trans-differentiation and migration.
Ajay AK; Zhao L; Vig S; Fujiwara M; Thakurela S; Jadhav S; Cho A; Chiu IJ; Ding Y; Ramachandran K; Mithal A; Bhatt A; Chaluvadi P; Gupta MK; Shah SI; Sabbisetti VS; Waaga-Gasser AM; Frank DA; Murugaiyan G; Bonventre JV; Hsiao LL
Cell Rep; 2022 Mar; 38(10):110473. PubMed ID: 35263586
[TBL] [Abstract][Full Text] [Related]
18. Blocking interleukin-6 trans-signaling protects against renal fibrosis by suppressing STAT3 activation.
Chen W; Yuan H; Cao W; Wang T; Chen W; Yu H; Fu Y; Jiang B; Zhou H; Guo H; Zhao X
Theranostics; 2019; 9(14):3980-3991. PubMed ID: 31281526
[No Abstract] [Full Text] [Related]
19. EGFR drives the progression of AKI to CKD through HIPK2 overexpression.
Xu L; Li X; Zhang F; Wu L; Dong Z; Zhang D
Theranostics; 2019; 9(9):2712-2726. PubMed ID: 31131063
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II contributes to renal fibrosis independently of Notch pathway activation.
Lavoz C; Rodrigues-Diez R; Benito-Martin A; Rayego-Mateos S; Rodrigues-Diez RR; Alique M; Ortiz A; Mezzano S; Egido J; Ruiz-Ortega M
PLoS One; 2012; 7(7):e40490. PubMed ID: 22792351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
